InterveXion
PrivateLast Round
Grant
Sep 30, 2022
Total Funding Raised
$52.71M
Company Overview
InterveXion Therapeutics is a biopharmaceutical company focused on developing immunotherapies to offer therapeutic options for patients affected by addiction, specifically targeting methamphetamine overdose and use disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InterveXion Comps
Public and private peers based on sector, stage, and business model.
InterveXion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2022 | ||||
| Grant | Oct 4, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Oct 12, 2017 | ||||
Grant | Jan 29, 2015 |
InterveXion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse (NIDA) | Grant |
| National Institutes of Health (NIH) | Grant |
| NIH HEAL Initiative | Grant |
| National Institute on Drug Abuse | Grant |
InterveXion Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InterveXion's valuation, stock price, and market status.
